Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

"Patients often require intensive hospital care as symptoms worsen, and our current treatment options are severely limited," explains Igdoura. "But now, there's hope." By studying late-onset cases, ...

The jail in Georgia's largest county, Fulton County, leaves its inmates vulnerable to "substantial risk of serious harm from ...

NATO and the European Union are ramping up efforts to persuade China to help get North Korea to stop sending troops and other ...

About 35% of patients diagnosed with cancer in Ontario had previously visited an emergency department, raising questions about access to routine care and oncology services.

Dizziness when lying down may be treatable with head positioning and medications. This article describes non-emergency and ...

Seven of the ballot measures passed, while three failed. Measures in Arizona, Colorado, New York, Maryland, Missouri, Montana and Nevada were approved by voters, while measures to expand abortion ...

Before his family publicly shared his diagnosis in 2023, they revealed in March 2022 that he had to step ... of neurology at University of Michigan Medicine, previously told TODAY.com.

Hepatic adenoma is a benign liver tumor associated with birth control and pregnancy. Learn the importance of diagnosing the ...

Sepsis is a life threatening illness that develops when an existing infection triggers an extreme immune system response in your body. When you experience an infection, your immune system releases ...

Of course, you can get them just fine today, now that the current I-bond rate is down ... (CPI), and given that inflation has slowed since 2022, the rate for I-bonds has also slowed, but it ...